Alex Pasteur joined Fidelity Biosciences in 2012 to establish a London office for the firm. He focuses on investment opportunities in pharmaceuticals and medical devices that are headquartered in Europe. Alex brings more than 10 years investing experience in the healthcare sector. He previously worked at MVM Life Science Partners LLP in the USA and Europe and was responsible for investments in Cara Therapeutics Inc., Vantia Ltd and Xention Pharma Ltd. Alex earned a MA in Natural Sciences and a PhD in Chemistry from Cambridge University.